Ligand validation:7CL3

9CS: (1R,2S,3S,4R,6S)-4,6-DIAMINO-3-[(3-AMINO-3-DEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]-2-HYDROXYCYCLOHEXYL 2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSIDE

9CS is a Ligand Of Interest in 7CL3 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7CL3_9CS_C_303	67%	49%	0.136	0.946	0.93	1.04	1	2	0	0	100%	1
7CL3_9CS_A_303	61%	56%	0.151	0.941	0.79	0.91	-	1	0	0	100%	1
7CL3_9CS_F_303	57%	54%	0.147	0.923	0.76	1.01	-	1	0	0	100%	1
7CL3_9CS_E_303	45%	48%	0.157	0.889	0.8	1.19	-	4	0	0	100%	1
7CL3_9CS_B_303	20%	33%	0.212	0.815	1	1.63	2	11	1	0	100%	1
7CL3_9CS_D_303	19%	42%	0.215	0.806	0.97	1.29	1	8	0	0	100%	1
7CL5_9CS_D_303	80%	50%	0.127	0.978	0.86	1.07	1	2	0	0	100%	1
6S0W_9CS_F_301	30%	70%	0.227	0.89	0.51	0.63	1	-	0	0	100%	0.7
7UUL_9CS_C_301	86%	35%	0.092	0.959	1.44	1.15	5	3	0	0	100%	1
5U1E_9CS_A_401	67%	30%	0.119	0.928	1.56	1.24	5	6	0	0	100%	1
2QIR_9CS_A_501	33%	47%	0.188	0.867	0.98	1.08	2	3	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.